|
|
Volumn 32, Issue 9, 2001, Pages 518-
|
|
Breast cancer tests: Her 2/neu versus FISH test
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOXORUBICIN;
GENE PRODUCT;
TRASTUZUMAB;
ASSAY;
BREAST CANCER;
CANCER SCREENING;
CLINICAL LABORATORY;
DATA ANALYSIS;
DECISION MAKING;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC APPROACH ROUTE;
DIAGNOSTIC ERROR;
DIAGNOSTIC TEST;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE AMPLIFICATION;
GENE EXPRESSION;
GENE OVEREXPRESSION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
INTERMETHOD COMPARISON;
LABORATORY DIAGNOSIS;
NOTE;
ONCOGENE NEU;
PERFORMANCE;
RELIABILITY;
SKILL;
VALIDATION PROCESS;
|
|
EID: 17944378990
PISSN: 00075027
EISSN: None
Source Type: Journal
DOI: 10.1309/3CVU-Y08K-G949-WYPL Document Type: Note |
|
Times cited : (1)
|
|
References (3)
|
